Fig. 1.
Forest plot depicting analysis of the risk of mortality at longest follow-up in patients treated with levosimendan vs placebo. LVEF Left ventricular ejection fraction, LCOS Low cardiac output syndrome, M-H Mantel-Haenszel
Forest plot depicting analysis of the risk of mortality at longest follow-up in patients treated with levosimendan vs placebo. LVEF Left ventricular ejection fraction, LCOS Low cardiac output syndrome, M-H Mantel-Haenszel